(Total Views: 473)
Posted On: 05/18/2025 5:59:40 PM
Post# of 154912
Homework for those who like digging in the weeds and running hypotheticals:
Which of the companies currently marketing a PD-L1 drug makes the most sense for partnering? Who has the cash? Who has their hands in other areas LL works that could more easily push new platform indications? Who has the stones to go big?
And on the surface I’d imagine Roche has to have the deepest burning down in their loins (medical phrase) since most the patients who survived were on their drug, right?
Which of the companies currently marketing a PD-L1 drug makes the most sense for partnering? Who has the cash? Who has their hands in other areas LL works that could more easily push new platform indications? Who has the stones to go big?
And on the surface I’d imagine Roche has to have the deepest burning down in their loins (medical phrase) since most the patients who survived were on their drug, right?
(14)
(0)
